Elevation of met5-enkephalin and β-endorphin hypothalamic content in rats receiving anorectic drugs: Differences between d-fenfluramine and d-amphetamine

L. Hársing, H. Y T Yang, S. Govoni, E. Costa

Research output: Contribution to journalArticle

30 Citations (Scopus)

Abstract

D-Fenfluramine, an anorectic that releases serotonin (5-HT), repeatedly injected in rats (15 mg/kg per day) enhanced the met5-enkephalin and β-endorphin content of the hypothalamus. The onset of this effect was slow, reaching a peak at 5 days; the increase in β-endorphin gradually declined toward control level while the drug was still being administered although that of met-enkephalin persisted for 15 days. The elevation of the opioid peptide content of the hypothalamus was temporally associated with a slowing in the rate of body weight increase. A transient, small, increase in striatal met-enkephalin content was also induced by repeated D-fenfluramine injections: however the metenkephalin content of frontal cortex, hippocampus and brainstem was not affected. A modification of the β-endorphin content of hypothalamus was not seen after acute injection of D-fenfluramine or D-amphetamine but an increase was observed during repeated treatment with D-fenfluramine. Repeated injections of D-amphetamine for 5 days (4.5 mg/kg per day) failed to increase either the met-enkephalin or the β-endophin content of the hypothalamus. These data suggest that the anorexia elicited by repeated injections of D-fenfluramine but not that elicited by D-amphetamine, includes a participation by hypothalamic and β-endosphin stores.

Original languageEnglish
Pages (from-to)141-145
Number of pages5
JournalNeuropharmacology
Volume21
Issue number2
DOIs
Publication statusPublished - 1982

Fingerprint

Endorphins
Fenfluramine
Appetite Depressants
Dextroamphetamine
Enkephalins
Methionine Enkephalin
Hypothalamus
Amphetamine
Injections
Pharmaceutical Preparations
Serotonin
Corpus Striatum
Opioid Peptides
Anorexia
Frontal Lobe
Brain Stem
Hippocampus
Body Weight

Keywords

  • anorectic drugs
  • hypothalamus
  • met-enkephalin
  • β-endorphin

ASJC Scopus subject areas

  • Cellular and Molecular Neuroscience
  • Drug Discovery
  • Pharmacology

Cite this

Elevation of met5-enkephalin and β-endorphin hypothalamic content in rats receiving anorectic drugs : Differences between d-fenfluramine and d-amphetamine. / Hársing, L.; Yang, H. Y T; Govoni, S.; Costa, E.

In: Neuropharmacology, Vol. 21, No. 2, 1982, p. 141-145.

Research output: Contribution to journalArticle

@article{26b37e9bdcbe4f27925a394ac65ebc1a,
title = "Elevation of met5-enkephalin and β-endorphin hypothalamic content in rats receiving anorectic drugs: Differences between d-fenfluramine and d-amphetamine",
abstract = "D-Fenfluramine, an anorectic that releases serotonin (5-HT), repeatedly injected in rats (15 mg/kg per day) enhanced the met5-enkephalin and β-endorphin content of the hypothalamus. The onset of this effect was slow, reaching a peak at 5 days; the increase in β-endorphin gradually declined toward control level while the drug was still being administered although that of met-enkephalin persisted for 15 days. The elevation of the opioid peptide content of the hypothalamus was temporally associated with a slowing in the rate of body weight increase. A transient, small, increase in striatal met-enkephalin content was also induced by repeated D-fenfluramine injections: however the metenkephalin content of frontal cortex, hippocampus and brainstem was not affected. A modification of the β-endorphin content of hypothalamus was not seen after acute injection of D-fenfluramine or D-amphetamine but an increase was observed during repeated treatment with D-fenfluramine. Repeated injections of D-amphetamine for 5 days (4.5 mg/kg per day) failed to increase either the met-enkephalin or the β-endophin content of the hypothalamus. These data suggest that the anorexia elicited by repeated injections of D-fenfluramine but not that elicited by D-amphetamine, includes a participation by hypothalamic and β-endosphin stores.",
keywords = "anorectic drugs, hypothalamus, met-enkephalin, β-endorphin",
author = "L. H{\'a}rsing and Yang, {H. Y T} and S. Govoni and E. Costa",
year = "1982",
doi = "10.1016/0028-3908(82)90153-8",
language = "English",
volume = "21",
pages = "141--145",
journal = "Neuropharmacology",
issn = "0028-3908",
publisher = "Elsevier Limited",
number = "2",

}

TY - JOUR

T1 - Elevation of met5-enkephalin and β-endorphin hypothalamic content in rats receiving anorectic drugs

T2 - Differences between d-fenfluramine and d-amphetamine

AU - Hársing, L.

AU - Yang, H. Y T

AU - Govoni, S.

AU - Costa, E.

PY - 1982

Y1 - 1982

N2 - D-Fenfluramine, an anorectic that releases serotonin (5-HT), repeatedly injected in rats (15 mg/kg per day) enhanced the met5-enkephalin and β-endorphin content of the hypothalamus. The onset of this effect was slow, reaching a peak at 5 days; the increase in β-endorphin gradually declined toward control level while the drug was still being administered although that of met-enkephalin persisted for 15 days. The elevation of the opioid peptide content of the hypothalamus was temporally associated with a slowing in the rate of body weight increase. A transient, small, increase in striatal met-enkephalin content was also induced by repeated D-fenfluramine injections: however the metenkephalin content of frontal cortex, hippocampus and brainstem was not affected. A modification of the β-endorphin content of hypothalamus was not seen after acute injection of D-fenfluramine or D-amphetamine but an increase was observed during repeated treatment with D-fenfluramine. Repeated injections of D-amphetamine for 5 days (4.5 mg/kg per day) failed to increase either the met-enkephalin or the β-endophin content of the hypothalamus. These data suggest that the anorexia elicited by repeated injections of D-fenfluramine but not that elicited by D-amphetamine, includes a participation by hypothalamic and β-endosphin stores.

AB - D-Fenfluramine, an anorectic that releases serotonin (5-HT), repeatedly injected in rats (15 mg/kg per day) enhanced the met5-enkephalin and β-endorphin content of the hypothalamus. The onset of this effect was slow, reaching a peak at 5 days; the increase in β-endorphin gradually declined toward control level while the drug was still being administered although that of met-enkephalin persisted for 15 days. The elevation of the opioid peptide content of the hypothalamus was temporally associated with a slowing in the rate of body weight increase. A transient, small, increase in striatal met-enkephalin content was also induced by repeated D-fenfluramine injections: however the metenkephalin content of frontal cortex, hippocampus and brainstem was not affected. A modification of the β-endorphin content of hypothalamus was not seen after acute injection of D-fenfluramine or D-amphetamine but an increase was observed during repeated treatment with D-fenfluramine. Repeated injections of D-amphetamine for 5 days (4.5 mg/kg per day) failed to increase either the met-enkephalin or the β-endophin content of the hypothalamus. These data suggest that the anorexia elicited by repeated injections of D-fenfluramine but not that elicited by D-amphetamine, includes a participation by hypothalamic and β-endosphin stores.

KW - anorectic drugs

KW - hypothalamus

KW - met-enkephalin

KW - β-endorphin

UR - http://www.scopus.com/inward/record.url?scp=0020003960&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0020003960&partnerID=8YFLogxK

U2 - 10.1016/0028-3908(82)90153-8

DO - 10.1016/0028-3908(82)90153-8

M3 - Article

C2 - 6278358

AN - SCOPUS:0020003960

VL - 21

SP - 141

EP - 145

JO - Neuropharmacology

JF - Neuropharmacology

SN - 0028-3908

IS - 2

ER -